Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization

Peer Review reports

Original Submission
15 Oct 2021	Submitted	Original manuscript
1 Nov 2021	Reviewed	Reviewer Report
20 Jan 2022	Reviewed	Reviewer Report
18 Feb 2022	Author responded	Author comments - Carlos King Ho Wong
Resubmission - Version 2
18 Feb 2022	Submitted	Manuscript version 2
21 Feb 2022	Reviewed	Reviewer Report
25 Feb 2022	Reviewed	Reviewer Report
3 Mar 2022	Author responded	Author comments - Carlos King Ho Wong
Resubmission - Version 3
3 Mar 2022	Submitted	Manuscript version 3
Publishing
3 Mar 2022	Editorially accepted
17 Mar 2022	Article published	10.1186/s12916-022-02321-4

Back to article page